Apoptotic, regenerative, and immune-related signaling in human islets from type 2 diabetes individuals.

Islet dysfunction is a primary cause of developing type 2 diabetes mellitus (T2DM). Events leading to islet failure are still poorly defined due to the complexity of the disease and scarcity of human T2DM islets. The aim of the present study was to identify cellular mechanisms involved in the T2DM pathophysiology by protein profiling islets obtained from T2DM individuals and age- and weight-matched controls using liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry and surface enhanced laser desorption/ionization time-of-flight mass spectrometry. In T2DM islets, multiple differentially expressed proteins correlated with insulin secretion. When these T2DM islet proteins were analyzed for differential pathway activation, three of the five most activated pathways were pathways of cell arrest and apoptosis (p53, caspase, stress-activated), one represented immune-response (Fas), and the most activated pathway was connected with proliferation and regeneration (E2F). Among the inactivated pathways, three out of five were pathways of proliferation and regeneration (insulin, PRL, PDGF). The present study is the first to report differential activation of specific pathways during T2DM islet deterioration. The information about alterations in pathway signaling patterns may open new ways to develop strategies aimed at restoring islet cell function and survival.

[1]  O. Schmitz,et al.  Glucose, Metformin, and AICAR Regulate the Expression of G Protein-coupled Receptor Members in INS-1 β Cell , 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[2]  L. Groop,et al.  Genome-wide association study for type 2 diabetes: clinical applications , 2009, Current opinion in lipidology.

[3]  B. Hering,et al.  Effect of short‐term culture on functional and stress‐related parameters in isolated human islets , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[4]  R. Costa,et al.  β-Cell Proliferation, but Not Neogenesis, Following 60% Partial Pancreatectomy Is Impaired in the Absence of FoxM1 , 2008, Diabetes.

[5]  P. Halban,et al.  Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. , 2008, The Journal of clinical endocrinology and metabolism.

[6]  Michael B Wheeler,et al.  The Identification of Potential Factors Associated with the Development of Type 2 Diabetes , 2008, Molecular & Cellular Proteomics.

[7]  M. Blandino-Rosano,et al.  Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide -1. , 2008, Journal of molecular endocrinology.

[8]  T. Otonkoski,et al.  EGF receptor in pancreatic beta-cell mass regulation. , 2008, Biochemical Society transactions.

[9]  C. Mathieu,et al.  Double-Stranded RNA Induces Pancreatic β-Cell Apoptosis by Activation of the Toll-Like Receptor 3 and Interferon Regulatory Factor 3 Pathways , 2008, Diabetes.

[10]  E. Wingender,et al.  Identification of dominant signaling pathways from proteomics expression data. , 2008, Journal of proteomics.

[11]  G. Cooper,et al.  Fas-Associated Death Receptor Signaling Evoked by Human Amylin in Islet β-Cells , 2008, Diabetes.

[12]  P. Butler,et al.  Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. , 2008, Endocrine reviews.

[13]  B. Boehm,et al.  The diabetes-linked transcription factor Pax4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1. , 2007, Human molecular genetics.

[14]  P. Bergsten,et al.  Evaluation of the SELDI‐TOF MS technique for protein profiling of pancreatic islets exposed to glucose and oleate , 2007, Proteomics.

[15]  N. Boudreau,et al.  Effects of decreased insulin‐like growth factor‐1 stimulation on hypoxia inducible factor 1‐α protein synthesis and function during cutaneous repair in diabetic mice , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[16]  Allan Vaag,et al.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.

[17]  P. Connell,et al.  High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth via a HIF-1alpha-dependent pathway. , 2007, Journal of molecular and cellular cardiology.

[18]  James D. Johnson,et al.  Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome , 2006, Proceedings of the National Academy of Sciences.

[19]  P. Bergsten,et al.  Protein profiling of pancreatic islets , 2006, Expert review of proteomics.

[20]  Marina A Gritsenko,et al.  Characterization of the human pancreatic islet proteome by two-dimensional LC/MS/MS. , 2006, Journal of proteome research.

[21]  P. Bergsten,et al.  Mitochondrial protein patterns correlating with impaired insulin secretion from INS‐1E cells exposed to elevated glucose concentrations , 2006, Proteomics.

[22]  H. Ellingsgaard,et al.  Low Concentration of Interleukin-1β Induces FLICE-Inhibitory Protein–Mediated β-Cell Proliferation in Human Pancreatic Islets , 2006, Diabetes.

[23]  P. Butler,et al.  Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes , 2006, Diabetologia.

[24]  A. F. Stewart,et al.  Molecular Control of Cell Cycle Progression in the Pancreatic β-Cell , 2006 .

[25]  Camillo Ricordi,et al.  The unique cytoarchitecture of human pancreatic islets has implications for islet cell function , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Bártfai,et al.  Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients. , 2006, Diabetes.

[27]  Mikhail M Savitski,et al.  Improving Protein Identification Using Complementary Fragmentation Techniques in Fourier Transform Mass Spectrometry* , 2005, Molecular & Cellular Proteomics.

[28]  P. Bergsten,et al.  Protein profiling of human pancreatic islets by two-dimensional gel electrophoresis and mass spectrometry. , 2005, Journal of proteome research.

[29]  U. Boggi,et al.  Functional and molecular defects of pancreatic islets in human type 2 diabetes. , 2005, Diabetes.

[30]  Christopher J. Rhodes,et al.  Type 2 Diabetes-a Matter of ß-Cell Life and Death? , 2005, Science.

[31]  P. Bergsten,et al.  Glucose-induced changes of multiple mouse islet proteins analysed by two-dimensional gel electrophoresis and mass spectrometry , 2005, Diabetologia.

[32]  K. Markides,et al.  Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography‐Fourier transform ion cyclotron resonance mass spectrometry , 2004, Proteomics.

[33]  U. Boggi,et al.  Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. , 2004, The Journal of clinical endocrinology and metabolism.

[34]  Walter C Willett,et al.  Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. , 2004, JAMA.

[35]  R. Perfetti,et al.  Role of caspases in the regulation of apoptotic pancreatic islet beta‐cells death , 2004, Journal of cellular physiology.

[36]  E. Slee,et al.  To die or not to die: how does p53 decide? , 2004, Oncogene.

[37]  S. Bonner-Weir,et al.  Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes. , 2003, The Journal of biological chemistry.

[38]  S. Kahn,et al.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes , 2003, Diabetologia.

[39]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[40]  C. Wrede,et al.  Protein Kinase B/Akt Prevents Fatty Acid-induced Apoptosis in Pancreatic β-Cells (INS-1)* , 2002, The Journal of Biological Chemistry.

[41]  X. Wang,et al.  TNF-Related Apoptosis-Inducing Ligand Death Pathway-Mediated Human Beta-Cell Destruction , 2002, Diabetologia.

[42]  D. Hochstrasser,et al.  Effect of Rosiglitazone on the Differential Expression of Diabetes-associated Proteins in Pancreatic Islets of C57Bl/6 lep/lep Mice* , 2002, Molecular & Cellular Proteomics.

[43]  R. Gomis,et al.  Pulsatile insulin release from islets isolated from three subjects with type 2 diabetes. , 2002, Diabetes.

[44]  M. Donath,et al.  Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. , 2001, Diabetes.

[45]  D. Hanahan,et al.  Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. , 1999, The Journal of clinical investigation.

[46]  J. Lakey,et al.  Activation and expression of ERK, JNK, and p38 MAP‐kinases in isolated islets of Langerhans: implications for cultured islet survival , 1999, FEBS letters.

[47]  C. Kahn,et al.  Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes , 1999, Cell.

[48]  B. Zhivotovsky,et al.  Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration. , 1998, The Journal of biological chemistry.

[49]  R. Alejandro,et al.  Tissue Culture Reduces la Antigen-bearing Cells in Rat Islets and Prolongs Islet Allograft Survival , 1982, Diabetes.